These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 14726206)
1. Lattice stabilization and enhanced diffraction in human p38 alpha crystals by protein engineering. Patel SB; Cameron PM; Frantz-Wattley B; O'Neill E; Becker JW; Scapin G Biochim Biophys Acta; 2004 Jan; 1696(1):67-73. PubMed ID: 14726206 [TBL] [Abstract][Full Text] [Related]
2. Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution. Schlatter D; Thoma R; Küng E; Stihle M; Müller F; Borroni E; Cesura A; Hennig M Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):513-9. PubMed ID: 15858260 [TBL] [Abstract][Full Text] [Related]
3. The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha. Patel SB; Cameron PM; O'Keefe SJ; Frantz-Wattley B; Thompson J; O'Neill EA; Tennis T; Liu L; Becker JW; Scapin G Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):777-85. PubMed ID: 19622861 [TBL] [Abstract][Full Text] [Related]
5. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Hutter D; Chen P; Barnes J; Liu Y Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068 [TBL] [Abstract][Full Text] [Related]
6. High-resolution diffracting crystals of intrinsically active p38alpha MAP kinase: a case study for low-throughput approaches. Diskin R; Engelberg D; Livnah O Acta Crystallogr D Biol Crystallogr; 2007 Feb; 63(Pt 2):260-5. PubMed ID: 17242519 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of TNF-alpha-induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways up-stream of caspase 3. Tudan C; Jackson JK; Blanis L; Pelech SL; Burt HM J Immunol; 2000 Nov; 165(10):5798-806. PubMed ID: 11067939 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase. Trejo A; Arzeno H; Browner M; Chanda S; Cheng S; Comer DD; Dalrymple SA; Dunten P; Lafargue J; Lovejoy B; Freire-Moar J; Lim J; Mcintosh J; Miller J; Papp E; Reuter D; Roberts R; Sanpablo F; Saunders J; Song K; Villasenor A; Warren SD; Welch M; Weller P; Whiteley PE; Zeng L; Goldstein DM J Med Chem; 2003 Oct; 46(22):4702-13. PubMed ID: 14561090 [TBL] [Abstract][Full Text] [Related]
10. Improved expression, purification, and crystallization of p38alpha MAP kinase. Bukhtiyarova M; Northrop K; Chai X; Casper D; Karpusas M; Springman E Protein Expr Purif; 2004 Sep; 37(1):154-61. PubMed ID: 15294293 [TBL] [Abstract][Full Text] [Related]
11. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. Waetzig GH; Seegert D; Rosenstiel P; Nikolaus S; Schreiber S J Immunol; 2002 May; 168(10):5342-51. PubMed ID: 11994493 [TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991 [TBL] [Abstract][Full Text] [Related]
13. Systematic study on crystal-contact engineering of diphthine synthase: influence of mutations at crystal-packing regions on X-ray diffraction quality. Mizutani H; Saraboji K; Malathy Sony SM; Ponnuswamy MN; Kumarevel T; Krishna Swamy BS; Simanshu DK; Murthy MR; Kunishima N Acta Crystallogr D Biol Crystallogr; 2008 Oct; 64(Pt 10):1020-33. PubMed ID: 18931409 [TBL] [Abstract][Full Text] [Related]
14. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. Tanoue T; Maeda R; Adachi M; Nishida E EMBO J; 2001 Feb; 20(3):466-79. PubMed ID: 11157753 [TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067 [TBL] [Abstract][Full Text] [Related]
16. The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. Li W; Nadelman C; Henry G; Fan J; Muellenhoff M; Medina E; Gratch NS; Chen M; Han J; Woodley D J Invest Dermatol; 2001 Dec; 117(6):1601-11. PubMed ID: 11886529 [TBL] [Abstract][Full Text] [Related]
17. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489 [TBL] [Abstract][Full Text] [Related]
18. Crystallization of MAP kinases. Lee SJ; Zhou T; Goldsmith EJ Methods; 2006 Nov; 40(3):224-33. PubMed ID: 16829129 [TBL] [Abstract][Full Text] [Related]
19. Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes. Ea HK; Uzan B; Rey C; Lioté F Arthritis Res Ther; 2005; 7(5):R915-26. PubMed ID: 16207333 [TBL] [Abstract][Full Text] [Related]
20. The impact of Lys-->Arg surface mutations on the crystallization of the globular domain of RhoGDI. Czepas J; Devedjiev Y; Krowarsch D; Derewenda U; Otlewski J; Derewenda ZS Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):275-80. PubMed ID: 14747703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]